+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo



Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo



Journal of Cardiovascular Pharmacology 6(5): 961-968



The role of alpha-adrenoceptor subtypes mediating vasoconstriction of large epicardial and small resistive coronary arteries was investigated in 26 open-chest dogs. The left circumflex coronary artery was perfused at a constant pressure. Large vessel vasomotion was determined by measurement of circumflex coronary arterial diameter (ultrasonic transit-time technique); the vasomotion of the small resistive coronary arteries was determined from calculated end-diastolic circumflex artery resistance. beta-Receptors were blocked by propranolol (2 mg/kg i.v.) and both vagal nerves were cut. In eight dogs, the intracoronary administration of the alpha 1-adrenoceptor agonist methoxamine (500 micrograms) increased calculated large vessel resistance by 18.8 +/- 5.7% and end-diastolic resistance by 9.5 +/- 0.3%. Intracoronary administration of the alpha 2-adrenoceptor agonist BHT 920 (500 micrograms) did not affect large vessel resistance, but increased end-diastolic resistance by 37.5 +/- 5.6%. In an additional 18 dogs, left cardiac sympathetic nerve stimulation induced an increase in large vessel resistance by 11.1 +/- 0.9% and in end-diastolic resistance by 31.8 +/- 3.0%. The increase in large vessel resistance was prevented by the alpha 1-adrenoceptor antagonist prazosin (1.2 mg/kg i.v.), which still permitted an increase in end-diastolic resistance by 23.0 +/- 3.2%. The increase in end-diastolic resistance was prevented by the alpha 2-adrenoceptor antagonist rauwolscine (0.2 mg/kg i.v.), which still permitted an increase in large vessel resistance by 11.9 +/- 2.4%. The calcium antagonist nifedipine (20 micrograms/kg i.v.) prevented both the increase in large vessel resistance and end-diastolic resistance during sympathetic stimulation.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042214755

Download citation: RISBibTeXText

PMID: 6209507


Related references

Lack of alpha adrenoceptor mediated vasoconstriction during low pressure perfusion in the canine coronary circulation. FASEB Journal 2(4): ABSTRACT 1818, 1988

Calcium influx-dependent and -independent alpha 1-adrenoceptor-mediated processes of vasoconstriction in vivo do not operate via different alpha 1-adrenoceptor subtypes. Journal of Cardiovascular Pharmacology 6(6): 1102-1108, 1984

Minimal alpha 1 adrenoceptor mediated and alpha 2 adrenoceptor mediated coronary vasoconstriction in the anesthetized swine. Naunyn-Schmiedeberg's Archives of Pharmacology 342(4): 422-428, 1990

The alpha 1 adrenoceptor mediated vasoconstriction to dobutamine and bdf 6143 4 chloro 2 2 imidazolin 2 ylaminoisoindoline is as sensitive to calcium influx modulation as the vasoconstriction to alpha 2 adrenoceptor activation. Federation Proceedings 44(5): 1464, 1985

Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat. Archives Internationales de Pharmacodynamie et de Therapie 278(1): 72-86, 1985

Effects of the irreversible alpha-adrenoceptor antagonists phenoxybenzamine and benextramine on the effectiveness of nifedipine in inhibiting alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in pithed rats. Naunyn-Schmiedeberg's Archives of Pharmacology 329(4): 404-413, 1985

Alpha 2 adrenoceptor-mediated vasoconstriction of arteries. Clinical Pharmacology and Therapeutics 34(5): 565-569, 1983

Pharmacological analysis of vasoconstriction of isolated canine ophthalmic and ciliary arteries to alpha-adrenoceptor agonists. Experimental Eye Research 45(2): 263-270, 1987

Potent alpha(2A)-adrenoceptor-mediated vasoconstriction by brimonidine in porcine ciliary arteries. Investigative Ophthalmology & Visual Science 42(9): 2049-2055, 2001

Renal alpha 1 adrenoceptor and alpha 2 adrenoceptor mediated vasoconstriction in dogs comparison of phenylephrine clonidine and guanabenz. Journal of Cardiovascular Pharmacology 6(SUPPL 5): S793-S798, 1984

Evaluation of alpha 1 adrenoceptor and alpha 2 adrenoceptor mediated vasoconstriction in the in situ autoperfused pulmonary circulation of the anesthetized dog. Journal of Pharmacology & Experimental Therapeutics 238(1): 217-223, 1986

Neurogenic beta and alpha adrenergic activation in large and small canine coronary arteries. Federation Proceedings 41(5): ABSTRACT 7763, 1982

Inhibition of alpha 2 adrenoceptor but not alpha 1 adrenoceptor mediated vasoconstriction by calcium entry blockers in humans. British Journal of Clinical Pharmacology 21(5): 590P, 1986

PP091Complex regulation of alpha-adrenoceptor-mediated vasoconstriction in human internal thoracic arteries. Clinical Therapeutics 35(8): E45-E46, 2013

Effects of hypercholesterolemia on alpha-1 adrenoceptor mediated vasoconstriction in rabbit common carotid arteries. Japanese Circulation Journal 57(7): 683, 1993